Latest News
FDA Moves to Facilitate Biosimilar Development
Yesterday, the Food and Drug Administration (FDA) announced long-overdue reforms to the biosimilar approval process that will boost biosimilar development and competition in the United States.
How Pharmaceutical Tariffs Will Affect US Health Care Costs
Tariffs on pharmaceuticals are under consideration following a Section 232 investigation into imports of medicines and active pharmaceutical ingredients (APIs).
MGA Releases New Report Quantifying the Economic Impact of Healthcare Distributors
Today, MGA released a report in collaboration with the HDA measuring the economic impact of healthcare distributors in the United States.
Who We Are
Matrix Global Advisors (MGA) is an economic policy consulting firm in Washington, DC, specializing in fiscal, healthcare, and tax policy matters. Drawing on years of policy experience, the MGA team writes white papers and expert reports, and offers strategic advice to our clients.




